Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohn Laing Infrastructure Fund Regulatory News (JLIF)

  • There is currently no data for JLIF

Trading Update Statement

7 Nov 2016 07:00

RNS Number : 4213O
John Laing Infrastructure Fund
07 November 2016
 

 

 

John Laing Infrastructure Fund Limited

 

Trading Update Statement

7 November 2016

 

JLIF, the international infrastructure investment company, today announces its Trading Update Statement ("TUS") for the period 1 July 2016 to 7 November 2016. 

HIGHLIGHTS

· Underlying portfolio growth on the rebased portfolio valuation for the nine months to the 30 September of £62.0 million, 0.56% ahead of expected growth from discount rate unwind

· Dividend of 3.41 pence per share paid in October, resulting in total dividends paid in 2016 of 6.82 pence per share

· Net Asset Value ("NAV") of £1,050.3m as at 30 September 2016 an 18.9% uplift of the NAV as at 31 December 2015

· NAV per share up 7.8% to 116.9 pence as at 30 September 2016 from 108.4 pence as at 31 December 2015

· Acquisitions since 1 July 2016 of approximately £53.5 million

 

Paul Lester CBE, Chairman of JLIF, said:

"I am pleased to be able to report another quarter of good performance by the Company, supported by further investment activity and underlying growth in the existing portfolio ahead of the unwind of the discount rate."

Andrew Charlesworth, Director of John Laing Capital Management (JLCM), Investment Adviser to JLIF, said:

"JLIF's Portfolio continues to perform well. While the market remains competitive, the new investments made so far this year show our ability to access new projects on a bilateral basis and at good value."

Valuation

JLIF's Portfolio of 60 infrastructure assets was valued as at 30 September 2016 at £1,113.8 million. This represents an increase on the valuation of the Portfolio as at 31 December 2015 of approximately £246.0 million (or 28.3%). A breakdown of the growth in Portfolio value is shown in the table below.

 

£000s

 

Portfolio Value as at 31 December 2015

867,830

 

Acquisitions

231,977

 

Disposals

(43,480)

 

Distributions

(62,582)

 

Growth due to changes in discount rates

19,277

 

Growth due to exchange rate movements

38,724

 

Rebased Portfolio Value as at 31 December 2015

1,051,846

 

Growth from discount rate unwind

57,291

5.33%

Growth from net value enhancements and other movements

4,665

0.56%

Portfolio Value as at 30 September 2016

1,113,802

 

 

Underlying growth in the nine months to 30 September 2016 was 5.89%, being 0.56% (or £4.7 million) ahead of the level of growth arising from the unwind of the discount rate (and adjusting for the timing of acquisitions, disposals and distributions in the period). Growth was ahead of expectations primarily as a result of profits from disposals in the period and other value enhancements such as refinancing of senior debt, insurance cost savings and better than forecast actual performance. This growth was offset by the negative impact of lower than forecast inflation, a reduction in long term UK deposit rate assumptions and cost provisions included within certain project valuations.

Acquisitions

In July 2016, JLIF completed the acquisition of an additional 13.5% interest in the Barcelona Metro Stations Line 9 Section II project. The interest was acquired from co-shareholder Acsa, Obras e Infraestructuras, S.A.U. ("Acsa"), a member of the Sorigué Group. As part of the same transaction, JLIF also acquired a 13.5% interest in the Barcelona Metro Stations Line 9 Section IV project, which runs further north to Section II. The aggregate consideration was the Euro-equivalent of approximately £53.5 million and was funded through JLIF's revolving credit facility.

Dividends

In early September 2016, JLIF announced a dividend in respect of the six months to the 30 June 2016 of 3.41 pence per share. The dividend was paid on 28 October 2016. As previously, the option to elect to receive a scrip dividend as an alternative to cash was offered to shareholders. This option resulted in the issue of 734,282 new ordinary shares. The total cash dividend paid was £29.7 million.

Portfolio Performance

As noted in the Interim Report, operational performance issues continue at Peterborough Hospital, Roseberry Park Hospital and the Edinburgh Schools projects. Appropriate provisions have been made within the valuation of the Portfolio to reflect the Company's view of the impact of the most likely outcome of these disputes.

Outlook

JLIF continues to review and selectively pursue a number of investment opportunities, both via bilateral deals originated through relationships with vendors and via competitive auction processes. JLIF is confident of continuing to find investment opportunities that meet its investment criteria and that represent good value for shareholders.

Note:

This Trading Update Statement aims to give an update of material events and transactions that have taken place during the period from 1 July 2016 to 7 November 2016 and their impact on the financial position of the Investment Group. This update reflects the Investment Adviser's and the Board's current views. They are subject to a number of risks and uncertainties and could change. Factors which could cause or contribute to such differences include, inter alia, general economic and market conditions and specific factors affecting the financial prospects or performance of individual investments within the portfolio of JLIF.

This update contains forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. Undue reliance should not be placed on any such statements because they speak only as at the dateof this document and, by their very nature, are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results and JLIF's actions to differ materially from those expressed or implied in the forward-looking statements.

This update has been prepared solely to provide additional information to shareholders as a body and should not be relied on by any other party or for any other purpose.

GIIN Number: K2UFLF.99999.SL.831

John Laing Capital Management Tel: + 44 (0) 20 7901 3326

Andrew Charlesworth

 

RLM Finsbury Tel: + 44 (0) 20 7251 3801

Faeth Birch

Philip Walters

Nidaa Lone

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFSMFMLFMSESF
Date   Source Headline
17th May 20182:28 pmRNSResults of AGM and EGM
11th Apr 20187:00 amRNSNotice of AGM and EGM
4th Apr 20184:28 pmRNSDirector/PDMR Shareholding
23rd Mar 20187:01 amRNS2017 Second Interim Dividend
23rd Mar 20187:00 amRNSResults for the year ended 31 December 2017
14th Mar 20186:23 pmRNSHolding(s) in Company
8th Mar 20187:00 amRNSNotice of Results
23rd Feb 20184:51 pmRNSHolding(s) in Company
29th Jan 20187:00 amRNSFurther update regarding liquidation of Carillion
16th Jan 20187:00 amRNSUpdate regarding liquidation of Carillion plc
15th Jan 20181:12 pmRNSKey Information Document Update
11th Jan 20184:00 pmRNSChange of Name of Administrator/ Company Secretary
21st Dec 201712:57 pmRNSKey Information Document
23rd Nov 20172:52 pmRNSHolding(s) in Company
21st Nov 20179:14 amRNSHolding(s) in Company
13th Nov 20176:25 pmRNSAudit Committee Changes
13th Nov 20177:00 amRNSTrading Update Statement
1st Nov 20177:00 amRNSTotal Voting Rights
30th Oct 20177:00 amRNSIssue of Equity
23rd Oct 20177:00 amRNSAgreement of Acquisition
29th Sep 20177:00 amRNSScrip Dividend Circular
11th Sep 20177:00 amRNS2017 First Interim Dividend
11th Sep 20177:00 amRNSInterim results
2nd Aug 20173:13 pmRNSHolding(s) in Company
1st Aug 201710:00 amRNSNotice of Results
17th Jul 201710:30 amRNSHolding(s) in Company
12th Jul 20172:16 pmRNSDirector Declaration
6th Jul 20177:00 amRNSDirectorate Change
1st Jun 20174:13 pmRNSCompletion of Acquisition
1st Jun 20177:00 amRNSTotal Voting Rights
19th May 20172:21 pmRNSResult of AGM
19th May 20177:00 amRNSTrading Update Statement
15th May 20177:00 amRNSScrip Allocation
11th Apr 20177:01 amRNSScrip Dividend Circular
11th Apr 20177:00 amRNSNotice of AGM
3rd Apr 20177:00 amRNSTotal Voting Rights
31st Mar 20174:40 pmRNSHolding(s) in Company
27th Mar 20173:25 pmRNSPlacing of 89,826,897 new ordinary shares
20th Mar 20177:03 amRNSPlacing of up to 89.8m of New Ordinary Shares
20th Mar 20177:02 amRNS2016 Second Interim Dividend
20th Mar 20177:00 amRNSPreliminary results for the year ended 31 Dec 2016
14th Feb 20177:00 amRNSNotice of Results
30th Dec 20167:00 amRNSCompletion of Acquisition
23rd Dec 20167:00 amRNSCompletion of Acquisition
21st Dec 20167:00 amRNSAgreement of Acquisition
13th Dec 201611:01 amRNSHolding(s) in Company
9th Dec 20167:00 amRNSAgreement of Acquisition
7th Nov 20167:00 amRNSTrading Update Statement
1st Nov 20167:00 amRNSTotal Voting Rights
27th Oct 20167:00 amRNSShare Issue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.